ASC Therapeutics (@asctherapeutics) 's Twitter Profile
ASC Therapeutics

@asctherapeutics

ASC Therapeutics develops biopharmaceuticals based on proprietary gene, CRISPR and allogeneic cell therapies

ID: 1419758794020556815

linkhttps://www.asctherapeutics.com calendar_today26-07-2021 20:37:45

96 Tweet

51 Followers

45 Following

Medhealth Outlook (@mdhealthoutlook) 's Twitter Profile Photo

Biotechnological Requirements for Patient Monitoring in Gene Therapies medhealthoutlook.com/biotechnologic… Oscar Segurado Oscar Segurado, MD PhD ASC Therapeutics ASC Therapeutics #tech #technology #CRO #clinicalresearch #Biotechnological #bio

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Establish robust internal communication channels to ensure everyone can express opinions, ask questions and feel trusted and valued forbes.com/sites/forbeste…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Clinical Leader Live’s interactive webinar on how ASC Therapeutics and other sponsors are adapting to DCTs … hybrid, virtual, remote, home-based,… Register for free here: event.on24.com/wcc/r/4314211/…

ASC Therapeutics (@asctherapeutics) 's Twitter Profile Photo

Elated to have our paper on Cell Therapies for GVHD published in Frontiers in Immunology! frontiersin.org/articles/10.33…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Our publication is now available OPEN ACCESS: Novel therapies for graft versus host disease with a focus on cell therapies frontiersin.org/articles/10.33…

Medical Affairs (@medicaffairs) 's Twitter Profile Photo

A personalized medicine approach through the combination of single biomarkers to develop signatures with AI, proven safe and effective in multiple oncology studies, still requires a significant effort to accelerate its adoption as standard of care news-medical.net/news/20231024/…

ASC Therapeutics (@asctherapeutics) 's Twitter Profile Photo

Our board member professor Behnam Sadeghi, Karolinska University Sweden, and our CEO Ruhong Jiang were keynote speaker and panelist at the 5th World Science and Technology Forum in Shenzen, China. Discussed our IND-cleared allogeneic cell therapy for GVHD

Our board member professor Behnam Sadeghi, Karolinska University Sweden, and our CEO Ruhong Jiang were keynote speaker and panelist at the 5th World Science and Technology Forum in Shenzen, China. Discussed our IND-cleared allogeneic cell therapy for GVHD
ASC Therapeutics (@asctherapeutics) 's Twitter Profile Photo

Hemophilia News Today highlights our potentially more durable and affordable second-generation gene therapy ASC618 in people with hemophilia A. hemophilianewstoday.com/news/dosing-be…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Ever wondered how far we’ve truly come in the realm of gene and cell therapies, and where we’re headed next? This captivating conversation with Oscar Segurado, the CMO of ASC Therapeutics, will satisfy your curiosity vial.com/blog/podcast/f…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Thanks, Charles Cormier, for this fun and inspiring interview. Always glad to talk about synthetic medicine and the mind-antibody connection youtu.be/dtAnB_GHmbU?si…

Thanks, Charles Cormier, for this fun and inspiring interview. Always glad to talk about synthetic medicine and the mind-antibody connection
youtu.be/dtAnB_GHmbU?si…
Medical Affairs (@medicaffairs) 's Twitter Profile Photo

The immunological revolution of cell-based therapies for autoimmune disorders has just started biopharmadive.com/news/lupus-cel…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Many patients with metastatic cancer have died, are dying and will die if we don’t replace the conventional way of classifying metastatic cancers according to their organ of origin and embrace AI-driven molecular, cellular and protein fingerprinting nature.com/articles/d4158…

Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Congratulations to the editors and fellow authors for the culmination of this extraordinary effort to coalesce industry perspectives on the development of gene therapies!

Congratulations to the editors and fellow authors for the culmination of this extraordinary effort to coalesce industry perspectives on the development of gene therapies!
Oscar Segurado, MD PhD (@oscarsegurado) 's Twitter Profile Photo

Join me at the Chief Medical Officer Summit 360Ëš in Boston on April 17-18! As a CMO, I am excited to discuss managing and motivating biotech teams while networking with like-minded professionals. Looking forward to gaining fresh insights and meeting fellow CMOs at #CMO360

Join me at the Chief Medical Officer Summit 360Ëš in Boston on April 17-18! As a CMO, I am excited to discuss managing and motivating biotech teams while networking with like-minded professionals. Looking forward to gaining fresh insights and meeting fellow CMOs at #CMO360